Cargando…
Use of central nervous system drugs in combination with selective serotonin reuptake inhibitor treatment: A Bayesian screening study for risk of suicidal behavior
BACKGROUND: Using other central nervous system (CNS) medications in combination with selective serotonin reuptake inhibitor (SSRI) treatment is common. Despite this, there is limited evidence on the impact on suicidal behavior of combining specific medications. We aim to provide evidence on signals...
Autores principales: | Lagerberg, Tyra, Sjölander, Arvid, Gibbons, Robert D., Quinn, Patrick D., D’Onofrio, Brian M., Hellner, Clara, Lichtenstein, Paul, Fazel, Seena, Chang, Zheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682954/ https://www.ncbi.nlm.nih.gov/pubmed/36440412 http://dx.doi.org/10.3389/fpsyt.2022.1012650 |
Ejemplares similares
-
Selective serotonin reuptake inhibitors and suicidal behaviour: a population-based cohort study
por: Lagerberg, Tyra, et al.
Publicado: (2021) -
Predicting risk of suicidal behaviour after initiation of selective serotonin reuptake inhibitors in children, adolescents and young adults: protocol for development and validation of clinical prediction models
por: Lagerberg, Tyra, et al.
Publicado: (2023) -
Associations between selective serotonin reuptake inhibitors and violent crime in adolescents, young, and older adults – a Swedish register-based study
por: Lagerberg, Tyra, et al.
Publicado: (2020) -
Selective Serotonin Reuptake Inhibitors and Violent Crime: A Cohort Study
por: Molero, Yasmina, et al.
Publicado: (2015) -
Effect of selective serotonin reuptake inhibitor treatment following diagnosis of depression on suicidal behaviour risk: a target trial emulation
por: Lagerberg, Tyra, et al.
Publicado: (2023)